基因工程猪的基因工程猪.

D K Cooper, E Koren, R Oriol

Lancet (London, England)

|September 11, 1993

概括

No abstract available in PubMed .

相关概念视频

您也可能阅读

通过共同作者、期刊和引用图与本文相关的文章。

排序

Same author

Standardizing the classification of skin tears: validity and reliability testing of the International Skin Tear Advisory Panel Classification System in 44 countries.

The British journal of dermatology·2019

Same author

A liposomal steroid nano-drug for treating systemic lupus erythematosus.

Lupus·2016

Same author

Adherence to controller asthma medications: 6-month prevalence across a US community pharmacy chain.

Journal of clinical pharmacy and therapeutics·2015

Same author

Chlorhexidine markedly potentiates the oxidants scavenging abilities of Candida albicans.

Inflammopharmacology·2015

Same author

Direct experimental observation of stacking fault scattering in highly oriented pyrolytic graphite meso-structures.

Nature communications·2014

Same author

Saliva: a 'solubilizer' of lipophilic antioxidant polyphenols.

Oral diseases·2012

Same journal

Assisted dying and the silencing of medicine's next generation.

Lancet (London, England)·2026

Same journal

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Lancet (London, England)·2026

Same journal

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

Lancet (London, England)·2026

Same journal

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Lancet (London, England)·2026

Same journal

Research priorities for characterising Bundibugyo virus.

Lancet (London, England)·2026

Same journal

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Lancet (London, England)·2026

查看所有相关文章

相关实验视频

基因工程猪的基因工程猪.

相关概念视频

Standardizing the classification of skin tears: validity and reliability testing of the International Skin Tear Advisory Panel Classification System in 44 countries.

A liposomal steroid nano-drug for treating systemic lupus erythematosus.

Adherence to controller asthma medications: 6-month prevalence across a US community pharmacy chain.

Chlorhexidine markedly potentiates the oxidants scavenging abilities of Candida albicans.

Direct experimental observation of stacking fault scattering in highly oriented pyrolytic graphite meso-structures.

Saliva: a 'solubilizer' of lipophilic antioxidant polyphenols.

Assisted dying and the silencing of medicine's next generation.

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Research priorities for characterising Bundibugyo virus.

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

相关实验视频

基因工程猪的基因工程猪.

相关概念视频

Standardizing the classification of skin tears: validity and reliability testing of the International Skin Tear Advisory Panel Classification System in 44 countries.

A liposomal steroid nano-drug for treating systemic lupus erythematosus.

Adherence to controller asthma medications: 6-month prevalence across a US community pharmacy chain.

Chlorhexidine markedly potentiates the oxidants scavenging abilities of Candida albicans.

Direct experimental observation of stacking fault scattering in highly oriented pyrolytic graphite meso-structures.

Saliva: a 'solubilizer' of lipophilic antioxidant polyphenols.

Assisted dying and the silencing of medicine's next generation.

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Research priorities for characterising Bundibugyo virus.

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.